A prospective observational study of problematic oral cannabinoid use
Crossref DOI link: https://doi.org/10.1007/s00213-017-4811-6
Published Online: 2017-12-17
Published Print: 2018-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ware, Mark A.
Martel, Marc O.
Jovey, Roman
Lynch, Mary E.
Singer, Joel
Funding for this research was provided by:
Valeant Pharmaceuticals (Canada)
License valid from 2017-12-17